Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter October 18, 2014

Reply to the article entitled “Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D” by Farrell et al., Clin Chem Lab Med 2014;52:1579–87

  • James Donnelly EMAIL logo , James Freeman , Kimberly Wilson , Victoria Shalhoub and Paul Sibley
From the journal Clinical Chemistry and Laboratory Medicine (CCLM)
https://doi.org/10.1515/cclm-2014-0856
Keywords: 25-hydroxyvitamin D; 25-OHD; automated 25-OHD assay; liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Corresponding author: James Donnelly, PhD, DABCC, FCACB, Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA, Phone: +1 914 524-2758, E-mail:

References

1. Farrell CJ, Soldo J, McWhinney B, Bandodkar S, Herrmann M. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D. Clin Chem Lab Med 2014;52:1579–87.10.1515/cclm-2014-0111Search in Google Scholar PubMed

2. Farrell C, Soldo J, Williams P, Herrmann M. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med 2012;50:1953–63.10.1515/cclm-2012-0522Search in Google Scholar PubMed

3. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012;58:531–42.10.1373/clinchem.2011.172155Search in Google Scholar PubMed

4. Herrmann M. The measurement of 25-hydroxy vitamin D – an analytical challenge. Clin Chem Lab Med 2012;50:1873–5.10.1515/cclm-2012-0526Search in Google Scholar PubMed

5. Moon HW, Cho JH, Hur M, Song J, Oh GY, Park CM, et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 2012;45:326–30.10.1016/j.clinbiochem.2011.12.025Search in Google Scholar PubMed

Received: 2014-8-25
Accepted: 2014-9-30
Published Online: 2014-10-18
Published in Print: 2015-4-1

©2015 by De Gruyter

From the journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Chemistry and Laboratory Medicine (CCLM)
Volume 53 Issue 5
Submit manuscript

Journal and Issue

Articles in the same Issue

Frontmatter
Editorial
High-sensitivity assays for cardiac troponins
Reviews
High sensitivity cardiac troponin assays in the clinical laboratories
Laboratory medicine as the science that underpins medicine: the “high-sensitivity” troponin paradigm
Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction
Cardiovascular Diseases
Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project
Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly
High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study
Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
Diagnosis of acute myocardial infarction in patients with renal insufficiency using high-sensitivity troponin T
General Clinical Chemistry and Laboratory Medicine
Active intervention in hospital test request panels pays
An approach to establish the uncertainty budget of catalytic activity concentration measurements in a reference laboratory
Uric acid: a potential biomarker of multiple sclerosis and of its disability
Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-dihydroxy-vitamin D
I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation
Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects
Diagnostic performance study of an antigen microarray for the detection of antiphospholipid antibodies in human serum
Dry ice exposure of plasma samples influences pH and lupus anticoagulant analysis
Reference Values and Biological Variations
A new robust statistical model for interpretation of differences in serial test results from an individual
Cancer Diagnostics
The value of red blood cell distribution width in endometrial cancer
Letters to the Editors
Serum high-sensitivity troponin concentrations in a multi-ethnic Asian population of stable chronic kidney disease patients
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform
Reply to the article entitled “Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D” by Farrell et al., Clin Chem Lab Med 2014;52:1579–87
Reply. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D. Authors’ response to the Letter to the Editor by Donnelly et al.
Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography
Interference of C-reactive protein with clotting times
Downloaded on 7.6.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2014-0856/html
Scroll to top button